Replies to post #13385 on Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

Well, the total 2b/3 CT called for 682 patients and 150 were for the Phase 2b , leaving about 500 for Phase 3. CEO CM mentioned that the cost per patient was about $20k , so I picked $10M. Hope it is less.
My point was there is sufficient money for running Data etc and doing at least Site recruitment and planning with the Warrant money.
I, of course want CEO and S/O to take a couple plane trips carrying an EUA around to some large possible customers and/or partners and Sell that news. ..GLTA...